SARS Diagnostics Workshop July 14 Would Facilitate Lab Resource Exchange
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center sees the severe acute respiratory syndrome outbreak as an opportunity to address the scientific challenges of developing new diagnostics when a disease remains ill-defined
You may also be interested in...
IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests
An IVD industry proposal to foster a new 510(k) mechanism for innovative analyte test kits would offer a timely alternative to "homebrew" diagnostic tests
IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests
An IVD industry proposal to foster a new 510(k) mechanism for innovative analyte test kits would offer a timely alternative to "homebrew" diagnostic tests
FDA, CDC Address Disease Outbreak Test Development In Wake Of SARS
The investigational device exemption process for diagnostic tests related to disease outbreaks should be expedited, FDA acknowledges